| 000 | 01509 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513003746.0 | ||
| 264 | 0 | _c19810720 | |
| 008 | 198107s 0 0 eng d | ||
| 022 | _a0001-6101 | ||
| 024 | 7 |
_a10.1111/j.0954-6820.1981.tb11586.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKarlberg, B E | |
| 245 | 0 | 0 |
_aCaptopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity. _h[electronic resource] |
| 260 |
_bActa medica Scandinavica _c1981 |
||
| 300 |
_a245-52 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAldosterone _xurine |
| 650 | 0 | 4 |
_aCaptopril _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrochlorothiazide _xtherapeutic use |
| 650 | 0 | 4 |
_aHypertension _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProline _xanalogs & derivatives |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aRenin _xblood |
| 700 | 1 | _aAsplund, J | |
| 700 | 1 | _aNilsson, O R | |
| 700 | 1 | _aWettre, S | |
| 700 | 1 | _aOhman, K P | |
| 773 | 0 |
_tActa medica Scandinavica _gvol. 209 _gno. 4 _gp. 245-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.0954-6820.1981.tb11586.x _zAvailable from publisher's website |
| 999 |
_c7015452 _d7015452 |
||